VetSheet

格隆溴銨 / 糖吡咯酯

Glycopyrronium (Glycopyrrolate)

Glycopyrronium bromide

別名: Robinul · Glycopyrrolate · Glycopyrronium bromide

由 VetSheet 獸醫團隊審訂更新於 2026年4月5日本內容以實證獸醫文獻為本

各物種劑量

此藥的劑量資料尚未收錄於 VetSheet 藥典,以下其他章節資料完整。開立處方前請參閱最新仿單。

概覽

​格隆溴銨​(又稱​糖吡咯酯​)是一種強效的抗膽鹼藥物及抗涎劑。在獸醫麻醉中主要用於減少口腔與支氣管分泌物、抑制迷走神經傳出活性,以及處理因施打強效鴉片類藥物所引起的心跳過緩。它也常與長效抗膽鹼酯酶藥物(如新斯狄明 neostigmine)併用,以拮抗神經肌肉阻斷劑的作用。

​臨床警告:​ 目前已不建議將格隆溴銨作為麻醉前給藥的常規程序。因為它會減少分泌物中的水分,導致呼吸道分泌物變得更加黏稠且難以清除。

作用機轉

Competitively blocks the action of acetylcholine at muscarinic receptors at the terminal ends of the parasympathetic nervous system → reverses parasympathetic effects (e.g., increases heart rate, reduces salivation).

​Clinical Pearl:​ Because of its quaternary ammonium structure, glycopyrronium cannot cross the blood-brain barrier. Therefore, it is devoid of central nervous system effects and does not cause central mydriasis, unlike atropine. It also has a longer duration of action compared to atropine.

安全性與警告

禁忌症

  • Concurrent use with alpha-2 adrenergic agonists is not recommended

不良反應

  • Tachycardia
  • Ventricular arrhythmias
  • Thickened, sticky airway secretions
  • Paradoxical bradycardia (at very low IV doses)

注意事項

  • ​Paradoxical Bradycardia:​ Administration of very low doses of glycopyrronium IV can cause exacerbation of bradyarrhythmias due to a vagal stimulatory effect. Giving another dose IV will usually cause an increase in heart rate.
  • ​Airway Secretions:​ Decreases the water content of oral and bronchial secretions, making them more sticky.
  • ​Opioid Bradycardia:​ It is better to monitor heart rate and give glycopyrronium to manage a low heart rate only if necessary, rather than as a routine premedication.

藥物交互作用

Barbiturates (alkaline drugs)Major

In vitro incompatibility; a precipitate may form if mixed together

SympathomimeticsModerate

Antimuscarinics may enhance the actions of sympathomimetics

Thiazide diureticsModerate

Antimuscarinics may enhance the actions of thiazide diuretics

AntihistaminesModerate

May enhance the anticholinergic activity of glycopyrronium

PethidineModerate

May enhance the anticholinergic activity of glycopyrronium

BenzodiazepinesModerate

May enhance the anticholinergic activity of glycopyrronium

PhenothiazinesModerate

May enhance the anticholinergic activity of glycopyrronium

Alpha-2 adrenergic agonistsMajor

Combining glycopyrronium and alpha-2 adrenergic agonists is not recommended due to conflicting cardiovascular effects

監測

  • Heart rate and rhythm (ECG)
  • Respiratory rate and airway patency

藥物動力學

吸收

Rapidly absorbed following IM or SC administration.

分佈

Does not cross the blood-brain barrier or placenta significantly due to its quaternary ammonium structure.

代謝

Undergoes minimal hepatic metabolism.

排除

Excreted primarily unchanged in the urine and feces.

過量

Tachycardias following an overdose of glycopyrronium are usually transient and do not require management. If severe ventricular arrhythmias occur, they may be treated with lidocaine.

可用產品

劑型

  • Injectable: 200 μg/ml solution

獸醫用

  • Robinul 200 μg/ml solution for injection

人用標示

  • Robinul 200 μg/ml solution for injection

各地核准狀態

United States✓ 已核准處方藥FDA/CVM
🐕 Dogs🐈 Cats
European Union✓ 已核准處方藥EMA
🐕 Dogs🐈 Cats

POM (Prescription Only Medicine)

United Kingdom✓ 已核准處方藥VMD
🐕 Dogs🐈 Cats

POM-V

暫無法規資料: 🇭🇰 HK · 🇹🇼 TW · 🇯🇵 JP · 🇰🇷 KR · 🇦🇺 AU

儲存與穩定性

Normal precautions should be observed. Store at room temperature and protect from light.

飼主須知

本藥物通常由獸醫師在診所或醫院的麻醉或手術期間施打。主要用於在麻醉期間安全地控制寵物的心跳速率,並減少過多的唾液與呼吸道分泌物。

VetSheet 藥物參考供合格獸醫專業人員作臨床決策輔助之用,不能取代專業判斷或廠商最新仿單。